These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 26549027)
21. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells. Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770 [TBL] [Abstract][Full Text] [Related]
22. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway. Kou B; Liu W; Tang X; Kou Q Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866 [TBL] [Abstract][Full Text] [Related]
23. Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling. Faresse N; Colland F; Ferrand N; Prunier C; Bourgeade MF; Atfi A EMBO J; 2008 Jul; 27(13):1804-15. PubMed ID: 18511908 [TBL] [Abstract][Full Text] [Related]
24. Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells. Sung JY; Park SY; Kim JH; Kang HG; Yoon JH; Na YS; Kim YN; Park BK Cell Death Dis; 2014 May; 5(5):e1224. PubMed ID: 24832596 [TBL] [Abstract][Full Text] [Related]
25. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression. Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266 [TBL] [Abstract][Full Text] [Related]
26. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells. Yang W; Gong X; Wang X; Huang C Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243 [TBL] [Abstract][Full Text] [Related]
27. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling. Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025 [TBL] [Abstract][Full Text] [Related]
28. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition. Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816 [TBL] [Abstract][Full Text] [Related]
29. Pin1 promotes transforming growth factor-beta-induced migration and invasion. Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136 [TBL] [Abstract][Full Text] [Related]
30. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Galliher AJ; Schiemann WP Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088 [TBL] [Abstract][Full Text] [Related]
31. Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway. Geng J; Fan J; Ouyang Q; Zhang X; Zhang X; Yu J; Xu Z; Li Q; Yao X; Liu X; Zheng J Oncotarget; 2014 Jul; 5(14):5700-11. PubMed ID: 25026293 [TBL] [Abstract][Full Text] [Related]
32. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Yoo YA; Kang MH; Kim JS; Oh SC Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246 [TBL] [Abstract][Full Text] [Related]
33. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines. Choi YJ; Baek GY; Park HR; Jo SK; Jung U PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321 [TBL] [Abstract][Full Text] [Related]
34. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Sengupta S; Jana S; Bhattacharyya A Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534 [TBL] [Abstract][Full Text] [Related]
35. Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway. Kou B; Liu W; Zhao W; Duan P; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q Oncol Rep; 2017 Dec; 38(6):3592-3598. PubMed ID: 29039572 [TBL] [Abstract][Full Text] [Related]
36. ShcA Protects against Epithelial-Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation. Muthusamy BP; Budi EH; Katsuno Y; Lee MK; Smith SM; Mirza AM; Akhurst RJ; Derynck R PLoS Biol; 2015 Dec; 13(12):e1002325. PubMed ID: 26680585 [TBL] [Abstract][Full Text] [Related]
37. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells. Ratz L; Laible M; Kacprzyk LA; Wittig-Blaich SM; Tolstov Y; Duensing S; Altevogt P; Klauck SM; Sültmann H Oncotarget; 2017 Apr; 8(15):25115-25130. PubMed ID: 28445989 [TBL] [Abstract][Full Text] [Related]
38. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells. Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350 [TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
40. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. Thacker PC; Karunagaran D PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]